Direxion Shares ETF Trust (CURE)
Verwaltungsgesellschaft · ARCX · Serie S000027486 · Auf SEC EDGAR ansehen ↗
- Nettovermögen
- $138.3M
- Bestände
- 66
- Stand
- 30. April 2026 veraltet
- Gewichtung der Top-10-Positionen
- 72,49%
- Effektive Anzahl von Positionen
- 11,7
- Positionen über 1%
- 25
Auf dieser Seite
- Fondstransaktionen Geld, das jeden Monat in den Fonds fließt und aus ihm abfließt, aus N-PORT-Einreichungen.
- Bestände Jede Position, die der Fonds derzeit hält, mit Gewichtungen.
- Sektoraufschlüsselung Aufteilung der Fondsbestände nach Sektoren.
- Institutionelle Eigentümer 13F-Institutionen, die angeben, diesen ETF zu halten.
- Ähnliche Fonds Andere Fonds mit überlappenden Beständen oder vergleichbarer Größe.
Fondsflüsse (SEC-gemeldet)
- Letzter Monat (Apr 2026)
- +$13.0M
- Quartalsende Apr 2026
- +$1.8M
- Letzte 12 Monate
- -$16.2M
Mai 2025 – Apr 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Vollständige Zusammensetzung 66 Beteiligungen
| Name | CUSIP | Wert | % | Bilanz | Kategorie | Land |
|---|---|---|---|---|---|---|
| GOLDMAN FINANCIAL | — | $25.9M | 18,73 | 25.909.233 | STIV | US |
| DREYFUS GOVERNMENT CASH MANAGE | — | $16.4M | 11,86 | 16.397.579 | STIV | US |
| ELI LILLY & COMPANY | 532457108 | $14.8M | 10,68 | 15.801 | EC | US |
| JOHNSON & JOHNSON | 478160104 | $11.0M | 7,99 | 48.053 | EC | US |
| AbbVie Inc. | 00287Y109 | $7.4M | 5,39 | 35.243 | EC | US |
| UnitedHealth Group Inc. | 91324P102 | $6.7M | 4,84 | 18.062 | EC | US |
| MERCK & COMPANY INC | 58933Y105 | $5.4M | 3,91 | 49.491 | EC | US |
| GOLDMAN SACHS LIQ ES FD A | — | $5.3M | 3,82 | 5.280.551 | STIV | US |
| Amgen Inc. | 031162100 | $3.7M | 2,69 | 10.737 | EC | US |
| Thermo Fisher Scientific Inc | 883556102 | $3.6M | 2,59 | 7.491 | EC | US |
| Intuitive Surgical Inc. | 46120E602 | $3.2M | 2,34 | 7.081 | EC | US |
| Gilead Sciences Inc. | 375558103 | $3.2M | 2,34 | 24.739 | EC | US |
| Abbott Laboratories | 002824100 | $3.1M | 2,28 | 34.673 | EC | US |
| PFIZER INC | 717081103 | $3.0M | 2,19 | 113.370 | EC | US |
| BRISTOL-MYERS SQUIBB COMPANY | 110122108 | $2.5M | 1,78 | 40.606 | EC | US |
| Danaher Corporation | 235851102 | $2.2M | 1,62 | 12.545 | EC | US |
| VERTEX PHARMACEUTICALS INC | 92532F100 | $2.2M | 1,57 | 5.065 | EC | US |
| Stryker Corporation | 863667101 | $2.2M | 1,56 | 6.868 | EC | US |
| CVS Health Corp | 126650100 | $2.1M | 1,53 | 25.368 | EC | US |
| Medtronic PLC | G5960L103 | $2.1M | 1,50 | 25.563 | EC | US |
| Mckesson Corp. | 58155Q103 | $2.0M | 1,44 | 2.443 | EC | US |
| Boston Scientific Corporation | 101137107 | $1.7M | 1,23 | 29.571 | EC | US |
| ELEVANCE HEALTH INC | 036752103 | $1.7M | 1,20 | 4.402 | EC | US |
| CIGNA GROUP (THE) | 125523100 | $1.5M | 1,10 | 5.254 | EC | US |
| REGENERON PHARMACEUTICALS INC | 75886F107 | $1.4M | 1,03 | 2.010 | EC | US |
| HCA Healthcare Inc | 40412C101 | $1.4M | 0,98 | 3.122 | EC | US |
| CENCORA INC | 03073E105 | $1.2M | 0,86 | 3.879 | EC | US |
| ZOETIS INC | 98978V103 | $968K | 0,70 | 8.418 | EC | US |
| Edwards Lifesciences Corporation | 28176E108 | $966K | 0,70 | 11.571 | EC | US |
| Cardinal Health, Inc. | 14149Y108 | $905K | 0,65 | 4.692 | EC | US |
| IDEXX Laboratories Inc. | 45168D104 | $893K | 0,65 | 1.593 | EC | US |
| BECTON DICKINSON & COMPANY | 075887109 | $846K | 0,61 | 5.676 | EC | US |
| Agilent Technologies Inc. | 00846U101 | $652K | 0,47 | 5.640 | EC | US |
| ResMed Inc. | 761152107 | $621K | 0,45 | 2.905 | EC | US |
| Waters Corporation | 941848103 | $605K | 0,44 | 1.957 | EC | US |
| Humana Inc. | 444859102 | $568K | 0,41 | 2.404 | EC | US |
| Biogen Inc | 09062X103 | $554K | 0,40 | 2.927 | EC | US |
| GE HEALTHCARE TECHNOLOGIES INC | 36266G107 | $553K | 0,40 | 9.086 | EC | US |
| IQVIA Holdings Inc. | 46266C105 | $536K | 0,39 | 3.383 | EC | US |
| METTLER-TOLEDO INTERNATIONAL INC | 592688105 | $518K | 0,37 | 406 | EC | US |
| Centene Corp. | 15135B101 | $500K | 0,36 | 9.315 | EC | US |
| DexCom Inc | 252131107 | $457K | 0,33 | 7.675 | EC | US |
| WEST PHARMACEUTICAL SERVICES INC | 955306105 | $427K | 0,31 | 1.434 | EC | US |
| Quest Diagnostics Incorporated | 74834L100 | $426K | 0,31 | 2.194 | EC | US |
| Steris PLC | G8473T100 | $424K | 0,31 | 1.957 | EC | US |
| Labcorp Holdings Inc | 504922105 | $424K | 0,31 | 1.652 | EC | US |
| VIATRIS INC | 92556V106 | $343K | 0,25 | 22.967 | EC | US |
| Zimmer Biomet Holdings Inc | 98956P102 | $326K | 0,24 | 3.951 | EC | US |
| Moderna Inc | 60770K107 | $319K | 0,23 | 6.933 | EC | US |
| Incyte Corporation. | 45337C102 | $318K | 0,23 | 3.334 | EC | US |
Sektoraufschlüsselung
Institutionelle Eigentümer (13F) 27 Einreicher
Institutionen, die diese ETF in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann zweimal für separate Optionskontrakte erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Institution | Wert | % der verfolgten 13F | Aktien | Typ | Stand |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | $6.337.605 | 16,05% | 56.500 | Kaufoption | 30. Juni 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.259.086 | 15,85% | 55.800 | Verkaufsoption | 30. Juni 2026 |
| GOLDMAN SACHS GROUP INC | $4.616.693 | 11,69% | 41.158 | Aktien | 30. Juni 2026 |
| CITADEL ADVISORS LLC | $4.430.715 | 11,22% | 39.500 | Verkaufsoption | 30. Juni 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.701.610 | 9,37% | 33.000 | Kaufoption | 30. Juni 2026 |
| JANE STREET GROUP, LLC | $3.320.232 | 8,41% | 29.600 | Verkaufsoption | 30. Juni 2026 |
| JANE STREET GROUP, LLC | $2.820.066 | 7,14% | 25.141 | Aktien | 30. Juni 2026 |
| Bullseye Investment Management, LLC | $1.745.618 | 4,42% | 16.374 | Aktien | 30. September 2025 |
| Belvedere Trading LLC | $1.435.776 | 3,64% | 12.800 | Kaufoption | 30. Juni 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.090.180 | 2,76% | 9.719 | Aktien | 30. Juni 2026 |
| JANE STREET GROUP, LLC | $886.143 | 2,24% | 7.900 | Kaufoption | 30. Juni 2026 |
| SBI Securities Co., Ltd. | $559.392 | 1,42% | 4.987 | Aktien | 30. Juni 2026 |
| Traynor Capital Management, Inc. | $531.353 | 1,35% | 4.737 | Aktien | 30. Juni 2026 |
| Summit Financial, LLC | $460.448 | 1,17% | 4.105 | Aktien | 30. Juni 2026 |
| Larson Financial Group LLC | $319.401 | 0,81% | 2.847 | Aktien | 30. Juni 2026 |
| Onyx Bridge Wealth Group LLC | $279.640 | 0,71% | 2.493 | Aktien | 30. Juni 2026 |
| StoneX Group Inc. | $227.620 | 0,58% | 2.316 | Aktien | 30. Juni 2026 |
| Qube Research & Technologies Ltd | $135.950 | 0,34% | 1.212 | Aktien | 30. Juni 2026 |
| SIMPLEX TRADING, LLC | $118.563 | 0,30% | 1.057 | Aktien | 30. Juni 2026 |
| UBS Group AG | $95.345 | 0,24% | 850 | Aktien | 30. Juni 2026 |
| Pinnacle Wealth Planning Services, Inc. | $48.682 | 0,12% | 434 | Aktien | 30. Juni 2026 |
| Farther Finance Advisors, LLC | $37.016 | 0,09% | 330 | Aktien | 30. Juni 2026 |
| OSAIC HOLDINGS, INC. | $21.841 | 0,06% | 194 | Aktien | 30. Juni 2026 |
| CIBC Private Wealth Group LLC | $12.528 | 0,03% | 150 | Aktien | 30. September 2025 |
| ROYAL BANK OF CANADA | $4.000 | 0,01% | 35 | Aktien | 30. Juni 2026 |
| MORGAN STANLEY | $141 | 0,00% | 1 | Aktien | 30. Juni 2026 |
| WELLS FARGO & COMPANY/MN | $105 | 0,00% | 1 | Aktien | 30. Juni 2026 |
Vergleichsfonds
Mehr von diesem Emittenten
| Fonds | AuM |
|---|---|
| SOXL Direxion Shares ETF Trust | $16.9B |
| SPXL Direxion Shares ETF Trust | $5.9B |
| TSLL Direxion Shares ETF Trust | $5.0B |
| TECL Direxion Shares ETF Trust | $4.7B |
| TMF Direxion Shares ETF Trust | $2.7B |
| FAS Direxion Shares ETF Trust | $2.0B |
| SOXS Direxion Shares ETF Trust | $1.9B |
| KORU Direxion Shares ETF Trust | $1.6B |
| TNA Direxion Shares ETF Trust | $1.5B |
| MUU Direxion Shares ETF Trust | $1.4B |
Ähnlich in der Größe
| Fonds | AuM |
|---|---|
| RVNU DBX ETF Trust | $138.4M |
| FAB First Trust Exchange-Traded Alp… | $138.8M |
| IZRL ARK ETF Trust | $139.3M |
| GMOM Cambria ETF Trust | $140.3M |
| ONEZ Elevation Series Trust | $140.6M |
| PXJ Invesco Exchange-Traded Fund Tr… | $138.0M |
| AUGW AIM ETF Products Trust | $138.0M |
| HTUS Capitol Series Trust | $138.0M |
| LGDX Tidal Trust III | $137.9M |
| COLO Global X Funds | $137.8M |